Expression of Bcl-xL in ovarian carcinoma is associated with chemoresistance and recurrent disease

A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry

Ildo Nicoletti, Graziella Migliorati, Maria Cristina Pagliacci et al. · Journal of Immunological Methods · 1991 · 4.6K citations

Flow Cytometry, Bioanalysis, Apoptosis +9

bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death

Lawrence Boise, Maribel González‐García, C E Postema et al. · Cell · 1993 · 3.1K citations · Full text

Hematological Malignancy, Cell Regulation, Dominant Regulator +10

Cancer Statistics, 2002

Ahmedin Jemal, Anish Thomas, Thomas S. Murray et al. · CA A Cancer Journal for Clinicians · 2002 · 2.9K citations · Full text

American Cancer Society, Cancer Statistics, Epidemiology +12

Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer

William P. McGuire, William J. Hoskins, Mark F. Brady et al. · New England Journal of Medicine · 1996 · 2.9K citations · Full text

Immunohistochemical analysis of in vivo patterns of Bcl-X expression.

Stanisław Krajewski, Maryla Krajewska, Ahmed Shabaik et al. · PubMed · 1994 · 426 citations

Signal Transduction, Autoimmune Disease, Laboratory Immunology +15